Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
about
Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic reviewIs There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma?Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumorsAdvances in systemic therapy for advanced pancreatobiliary malignanciesCancer review: CholangiocarcinomaCholangiocarcinomaSelective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver MalignanciesYttrium-90 microspheres: a review of its emerging clinical indicationsClassification, diagnosis, and management of cholangiocarcinomaUpdate on the Diagnosis and Treatment of Cholangiocarcinoma.Selective internal radiation therapy with SIR-Spheres in hepatocellular carcinoma and cholangiocarcinoma.Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma.Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.Imaging of malignancies of the biliary tract- an update.Intrahepatic cholangiocarcinoma: expert consensus statement.PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment EfficacyExtensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic CholangiocarcinomaCholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.Impact of medical and surgical intervention on survival in patients with cholangiocarcinomaYttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety studyRadioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study.Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.Intrahepatic cholangiocarcinoma: current perspectives.Intra-arterial embolotherapy for intrahepatic cholangiocarcinoma: update and future prospects.Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma.Evidence-based integration of selective internal radiation therapy into the management of cholangiocarcinoma.Multimodality treatment of intrahepatic cholangiocarcinoma: A review.Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma.The role of interventional radiology in the treatment of intrahepatic cholangiocarcinoma.Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma.Locoregional Therapies of Cholangiocarcinoma.Improving patient selection for selective internal radiation therapy of intra-hepatic cholangiocarcinoma: A meta-regression study.Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.Decision Making: Intra-arterial Therapies for Cholangiocarcinoma-TACE and TARE.Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma.Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results.90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.Cholangiocarcinoma - evolving concepts and therapeutic strategies.
P2860
Q26781036-F89B91B1-3E37-4ADB-874C-50B22852EFEDQ26796522-D738F598-51EC-4941-AAE2-F89AD2070A0FQ26799046-6F466BAC-84D7-492A-B91F-2EC8F7503D77Q26822703-1F78DD1E-864E-40B2-8232-5E30180AA9E6Q26865200-03E3047C-2F89-4F46-A583-B023B5D5FFE6Q27001694-C3ADF200-EADC-4F31-B9BE-7FD155964CF9Q28071594-A996EF65-C6D4-4564-9FC8-BE86AEF7F32EQ28083856-CB727D45-BD84-434E-8CF0-74C32FD7D9CFQ28275153-0F8676EA-C1D3-4C3E-A1AA-139405831E8BQ30238895-0F742C90-5D83-4CA1-A65D-90C4A5B5695DQ33593257-84DC5654-8C2F-4C9A-9713-DEE35B225665Q33844564-35CE7DAF-9066-4235-9DC9-A5DE290BF034Q34045215-694CD100-EF9F-4AD8-8386-C5521929D846Q34650742-8F121119-9254-4CA1-8B37-EFB849AD851EQ35046078-564A470E-4EE0-47A7-855B-BCF165AF920CQ35093239-CB481D1C-512E-4F70-8AE9-8E9DE9576BA7Q35924971-FA4F2B92-8D76-4E96-A6BF-99E0A257E77EQ36194191-34062A5A-CB7A-4F98-B32F-7156BFFA864FQ36592123-C3A82A30-4B70-4A37-BB96-97A1BBFD1505Q36962011-4459B734-FF59-4F07-ACE0-FB0F51AFF655Q37112614-AEE86274-AD7C-4EBE-A094-8C10CCC21075Q37151082-CFA2C092-EC63-4E8D-89C0-AF2D4F46D738Q37525291-9E148B2A-4E3B-460B-8FFC-33732D1D887DQ37601096-2222BB8D-CACD-48A4-B354-8F60D3540EDFQ37669928-42B05917-937D-4264-BF38-6359B2EACFC8Q37675072-EB2D861A-5356-420A-917B-96C5DEE28AB5Q38179344-FCAE77D0-B382-45E9-B50E-E9FB6DD57DAAQ38283685-6898029D-9308-4B0C-8098-5CE3140E58F8Q38707365-98145773-10B7-4F65-8EA4-713EC7AA143CQ38739690-4930C5F5-B86C-49C6-A94C-35AB53CF486AQ38778958-CA28BCC7-9DFE-41F3-A119-8EF1FF58E409Q38825699-F5CDEF77-5E70-4A2A-8507-44440A0DA17CQ38947234-554343FC-371F-44B2-8BFB-20AD702F4E94Q38972508-AED1D333-E1A9-4DAF-A01D-5AC29B219F88Q39048862-F7C4D7E0-7673-471C-A236-52BE36E52AEEQ39349626-6603C25E-ADE4-4CDE-B893-A08AFCCEF156Q41726331-960E96E2-B724-4888-AC26-D346046F46DEQ41951208-1E980FE6-822E-46C8-BA1B-4B2CCAA8BC92Q45207818-4713C96C-C43C-43FB-A81B-61E67975C9E0Q46087686-DB751617-E1AB-4308-8F7C-B5C25CBD5BF4
P2860
Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Transarterial hepatic yttrium- ...... iated with prolonged survival.
@ast
Transarterial hepatic yttrium- ...... iated with prolonged survival.
@en
Transarterial hepatic yttrium- ...... iated with prolonged survival.
@nl
type
label
Transarterial hepatic yttrium- ...... iated with prolonged survival.
@ast
Transarterial hepatic yttrium- ...... iated with prolonged survival.
@en
Transarterial hepatic yttrium- ...... iated with prolonged survival.
@nl
prefLabel
Transarterial hepatic yttrium- ...... iated with prolonged survival.
@ast
Transarterial hepatic yttrium- ...... iated with prolonged survival.
@en
Transarterial hepatic yttrium- ...... iated with prolonged survival.
@nl
P2093
P1476
Transarterial hepatic yttrium- ...... ciated with prolonged survival
@en
P2093
Agnes Schön
Barbara Rauch
Christoph T Trumm
Eva-Maria Dürr
Fabian Bamberg
Frank T Kolligs
Maximilian F Reiser
Philipp M Paprottka
Ralf-T Hoffmann
Thomas K Helmberger
P2888
P304
P356
10.1007/S00270-011-0142-X
P577
2011-03-24T00:00:00Z
P6179
1043959992